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ABSTRACT 
Streptococcus pneumoniae is an important human pathogen, causing potentially life-
threatening infections such as pneumonia and meningitis. Until recently, it was almost 
uniformly susceptible to penicillin and other antibiotics. However, research during the last 
few years has shown a dramatic increase in the levels of resistance of S. pneumoniae to 
several classes of antibiotics. Antibiotic resistance is a rapidly evolving problem of 
worldwide importance. Although antibiotic resistance is related to antibiotic use, the 
relationship is a complex one that requires further evaluation. 
Purpose: The purpose of this project was to provide baseline information on the levels of 
antibiotic resistance of Streptococcus pneumoniae for the province of Newfoundland and 
Labrador and to determine the relationship between different patient factors and 
resistance. We also compared the accuracy of various methods of susceptibility testing 
as well as described the trends in outpatient antibiotic consumption within Newfoundland 
and Labrador between 1997 and 2000. 
Methods: Isolates were collected from various regions of the province between January 
and December 2000. Patient demographics, including sex, age, specimen source and 
geographic location, were submitted with the isolates. Susceptibility testing was 
performed according to standard protocols using both disk diffusion and the E-test system. 
Information on antibiotic use was provided by IMS HEALTH Canada for the years of 1997 
to 2000. 
Results: The levels of antibiotic resistance of S. pneumoniae as described by this study 
are comparable to the levels of resistance described elsewhere in Canada. Isolates 
tested during this study showed evidence of resistance to multiple antibiotics. Increased 
levels of resistance were shown in isolates retrieved from non-sterile sites, children and 
the elderly. There was little variation in the levels of resistance in isolates obtained from 
males and females. The E-test System was shown to provide a more specific 
susceptibility profile than disk diffusion. Between 1997 and 2000, the outpatient use of 
tetracyclines, trimethoprim and penicillins showed a steady decline while the use of 
cephalosporins and macrolides declined initially and then increased. Fluroquinolones 
were the only class of antibiotic studied that showed an increase in public consumption. 
Conclusion: Limitations in isolate availability and patient information as well as a lack of 
information regarding regional antibiotic consumption prevented any correlations from 
being made between resistance levels and patient risk factors or community antibiotic use. 
However, this study does indicate that antibiotic resistance is a significant problem in 
Newfoundland and Labrador that will require further evaluation. 
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1.0 INTRODUCTION 
People had been using molds to treat infections for more than 2500 years (World 
Book, 1998). Then, in 1928, Alexander Fleming observed, for the first time, a mold of the 
genus Penicillium that produced a substance that had the ability to destroy bacteria 
(Pelczar eta/., 1993). This substance, given the name penicillin, became known 
worldwide as 'the wonder drug' because of its effective treatment of potentially fatal 
infections. 
Florey and colleagues showed that penicillin was an effective form of treatment for 
staphylococcal and streptococcal infections in February 1941 (Wilson, 1976). Their first 
patient was a policeman in Oxford, England who had scratched his face on a rose bush 
and subsequently developed local staphylococcal cellulitis followed by a secondary 
streptococcal infection complicated by orbital osteomyelitis and pneumonia. His initial 
treatment with sulfapyridine was unsuccessful. On February 12, the patient received an 
intravenous injection of 400 mg of crude penicillin followed by 100 mg every three hours. 
This treatment was continued for five days. The patient showed a rapid improvement, but 
after administering 4.5 gm's of penicillin the drug supply was exhausted. He lived for ten 
more days before succumbing to the infection. Despite the fatal result in this case, it was 
shown that penicillin had great promise(Wilson, 1976). 
Scientists and physicians began to assume that they finally had the upper hand in 
the battle against microorganisms. However, less then 20 years after the discovery of 
penicillin, the first known evidence of bacterial resistance to penicillin was observed in a 
mouse model in 1943 (Schmidt and Sesler, 1943). 
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In the decades following Fleming's discovery, the widespread availability of 
penicillin and other antimicrobial compounds led to a dramatic reduction in illness and 
death from infectious diseases. There were great advances in controlling diseases, such 
as tuberculosis (Gordon eta/., 2000). During this time, many countries also saw 
improvements in sanitation, housing and nutrition, which helped in the fight against 
infectious diseases. 
Despite the improvements in controlling illness caused by microorganisms, it has 
been shown in recent years that resistance to treatment with first-line drugs in bacterial 
pathogens ranges from zero to almost 100%. Ineffective therapy due to antimicrobial 
resistance has been associated with increased human suffering, lost productivity and 
often death (WHO, 2001). The increasing levels of drug resistance have been described 
as a threat to global stability and national security (WHO, 2001). 
Streptococcus pneumoniae is currently a major invasive bacterial pathogen of 
children and older adults, which is noteworthy because of the worldwide emergence of 
resistance to multiple antibiotics. This project will take a closer look at the current level of 
antibiotic resistance in Streptococcus pneumoniae, also referred to as pneumococcus, 
within the province of Newfoundland and Labrador. It will look at how various factors may 
be contributing to the problem, including the prescription rates of antibiotics commonly 
used to treat pneumococcal infections, as well as assess the efficacy of methodologies 
used to determine the level of resistance in this organism. 
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2.0 LITERATURE REVIEW 
2.1 Antibiotic Resistance 
Much of the research on antibiotic resistance has been aimed at determining the 
mechanisms by which microbes develop resistance and the means by which organisms 
transmit these characteristics to subsequent generations. Bacteria acquire resistance 
against an antibiotic as a form of adaptation under biochemical stress. These organisms 
may have intrinsic/natural or acquired resistance (Bezoen eta/., 2001). 
Intrinsic/natural resistance is inherent to the organism and is generally mediated 
through the shape and constituents of the organism. An example of natural resistance 
occurs in Pseudomonas aeruginosa, which has never been sensitive to chloramphenicol 
at any dose (Cunha, 2000). The natural resistance of Pseudomonas is due to the 
presence of multidrug efflux pumps with chromosomally-encoded antibiotic resistance 
genes and decreased outer membrane permeability. 
Acquired antibiotic resistance occurs if an organism which was once sensitive to a 
drug eventually becomes resistant to it (Cunha, 2000). Acquired resistance is sub-
categorized by some into relative or absolute resistance. Relative acquired resistance 
refers to the gradual increase over time of the minimal inhibitory concentration (MIC) of a 
particular antibiotic. Absolute resistance, in contrast, occurs when there is a single-step 
mutation that occurs during or after therapy which increases the MIC of a r reviously 
susceptible isolate to extremely high levels which are unachievable using therapeutic 
doses (Cunha, 2000). 
Acquired resistance can occur either by chromosomal mutation or DNA transfer. 
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Chromosomal mutations can occur within the bacterial genome at anytime, with or without 
the presence of antibiotic compounds in the environment. DNA transfer, in contrast, 
occurs when an organism receives resistance genes by taking up functional DNA from 
another bacterium. In both situations, organisms gain resistance to an antibiotic without 
selective pressure. Selective pressure refers to the environmental conditions that 
enhance the ability of bacteria to develop resistance to antibiotics and to proliferate. 
DNA transfer can occur in three different ways. When bacteria die, the soluble 
DNA remains in the environment where it can be picked up by other bacteria through a 
process known as transformation. The second situation is through the process of 
transduction, which oecurs when DNA is transferred between bacteria through 
bacteriophages, viruses that infect bacteria. The third situation occurs when there is direct 
cell-to-cell contact followed by the formation of a channel between organisms through 
which DNA, in the form of plasmids, can pass. This is referred to as conjugation. 
Microbes resist antibiotics by a number of specific mechanisms including alteration 
of the target site, enzymatic detoxification of the antibiotic, elimination of ports of entry to 
the cell, production of pumps that export antibiotics out of the cell, decreased drug 
accumulation or the bypass of an antibiotic sensitive step (Bezeon eta/., 2001 and 
Murray, 1995). Of these specific mechanisms, changes to the target site, detoxification 
and decreased drug accumulation are the direct result of chromosomal mutation or may 
be due to the presence of a plasmid within a bacterial species (Murray, 1995). Microbes 
which have the ability to bypass an antibiotic sensitive step are primarily the result of 
acquired foreign DNA (Murray, 1995). 
Natural or absolute acquired antibiotic resistance cannot be overcome by 
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increasing the antibiotic concentrations at clinically achievable levels (Cunha, 2000). In 
contrast, acquired relative resistance may be overcome by achieving blood and tissue 
concentrations of two to four times or greater the MIC of relative resistant isolates (Cunha, 
2000). 
Resistance becomes a problem when it presents as a resistant bacterial infection, 
not in an isolated bacterium (Cunha, 2000). The clinical problem emerges when 
susceptible strains are eliminated, permitting the resistant microbial flora to flourish and in 
some environments, to gain prominence. 
Several key factors led to the increase in antibiotic resistance in the post-World 
War II era. First of all, there was a worldwide dismantling of the public health 
infrastructure, especially in the area of infectious disease surveillance (Berkelman eta/., 
1994, Binder eta/., 1999 and Cohen, 1999). Complacency, decreased funding and 
resources and competing public health priorities led to a transfer of emphasis from 
infectious diseases to other areas (Cohen, 1999). These factors resulted in a weak public 
health surveillance system which was incapable of adequately evaluating the burgeoning 
problem of clinically significant antibiotic resistance. In addition, there was a disconnect 
between national and international public health systems which made it difficult to assess 
the problem on a larger scale. The recent threat of severe acute respiratory syndrome 
(SARS) has drawn attention to need for collective international public health action against 
diseases which threaten public safety, including antibiotic resistant diseases. 
Then during the 1980s, major drug manufacturers turned their research away from 
developing new antibacterial treatments because the tools seemed to be in place for the 
elimination of infectious disease (Culotta, 1994). From the marketing perspective, it was 
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more profitable for phannaceutical companies to tum their efforts toward other newer 
classes of drugs, such as those to combat chronic diseases, fungal and viral infections, 
that had a limited number of approved drugs, but a huge potential market. With a list of 
more than 1 00 approved antibiotics, there was a greater fight to obtain a share of the 
phannaceutical market with new antibacterial agents. Research and development in this 
area became less profitable. 
In recent years, there are a number of additional factors that are affecting the 
emergence and spread of resistant organisms. These factors include: 
• The development of mutations in resistance genes of bacteria. Mutational events in 
bacteria were originally thought to be rare events (Cunha, 2000). However, 
mutations in genes that encode key metabolic functions play a key role in the 
development of resistance to drugs like rifampin, streptomycin, ethambutol and 
fluoroquinolones (Cunha, 2000). These types of mutations transfonn susceptible 
organisms into resistant ones. However, mutations in preexisting resistance genes 
may function to increase the level of resistance to specific antibiotics or expand the 
spectrum of resistance. 
• 
• 
The exchange of genetic information among bacteria in which resistance genes are 
transmitted to new hosts. 
The development of environmental conditions in communities and hospitals that 
facilitate the development of resistant organisms. Expanded use of antibiotics in 
hospitals and in sites outside hospitals (i.e., long-tenn care facilities, day care 
centers, animal feedlots and other agricultural sites) increase the selective pressure 
for resistant organisms to emerge in these settings. 
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• The proliferation and spread of resistant bacteria. Resistance originates as a local 
phenomenon but can quickly expand to global proportions. Any localized problem 
can be transported because international travel can carry organisms from one 
country to another. 
• The inability of some laboratory testing methods to detect emerging resistance 
phenotypes. Recent proficiency testing studies have highlighted the difficulties that 
laboratories experience in detecting several of the newer bacterial resistance 
mechanisms with current laboratory methods (T enover, 2001 ). Data from 
proficiency testing studies conducted by the Centre for Disease Control suggest 
that laboratories not only have difficulty detecting resistant strains, but often do not 
follow National Committee for Clinical Laboratory Standards (NCCLS) guidelines 
regarding the appropriate antibiotics to test and report (Tenover eta/., 1999 and 
NCCLS, 2000). 
With growing concern over the impact of antibiotic resistant organisms, the 
Canadian Committee on Antibiotic Resistance (CCAR) released a report in 2002 which 
provided information on the burden that antibiotic resistance is creating for the Canadian 
health care system (CCAR, 2002). The CCAR estimates that drug susceptible infections 
currently cost between $260 and $553 million each year in Canada. Its model suggests 
that infections due to resistant organisms add $14.2-25.5 million in direct hospitalization 
costs to the annual cost of health care in Canada. Screening of patients during hospital 
admission to detect carriers of resistant organisms add another $10.3 million while the 
precautions needed to prevent the spread of resistant organisms between patients and 
carriers add $15.9 million more to the budget. These figures will continue to increase as 
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the prevalence of drug resistance increases. Therefore, antibiotic resistance creates a 
substantial burden for the health care system. 
2.2 Environmental Issues 
Antibiotic resistance is directly related to antibiotic use (Baquero, 1996). In a 
bacterial population, a small number of organisms may be resistant to a particular 
antibiotic due to intrinsic resistance or chromosomal mutation. If their environment 
remains unchanged, resistance provides no advantage. However, when exposed to an 
antibiotic, resistant organisms will flourish while the majority of the population will be 
inhibited or killed. 
The majority of antibiotic use actually occurs in two areas: in animals and the 
community. Within these areas combined, approximately 75% of the antibiotic use is 
thought to be of questionable therapeutic value (Harrison eta/., 1998). 
There are three uses for antibiotics in animals: prophylaxis, treatment and growth 
promotion. Half of all antibiotics are used to treat animals as growth promoters in livestock 
and to rid cultivated produce of harmful bacteria (van den Bodaard and Stobberingh, 
1999). The ideology behind their use as growth promoters is that antibiotics fed at 
subtherapeutic concentrations enhance the digestion of feed by reducing normal intestinal 
flora which competes with the host for nutrients and improve performance in food 
producing animals by preventing disease through the elimination of harmful intestinal 
bacteria (Bezoen eta/., 2001, McKellar, 1998 and Wegener eta/., 1999). The ongoing 
low-level dosing of antibiotics for growth and prophylaxis results in the development of 
resistance in bacteria in livestock by creating an environment where resistant organisms 
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may flourish. This selective pressure ultimately increases the likelihood of new resistant 
strains 'jumping' between animal species which are often kept in close proximity (WHO, 
2001). 
The amount of bacterial transference between animals and humans cannot be 
properly assessed because of a limited amount of data. However, Bezoen eta/. (2001) 
suggested that there are four possible routes (two direct and two indirect) through which 
antibiotic resistant bacteria may be transferred between humans and animals. 
• People directly in contact with animals or animal feces, such as farmers and 
slaughterhouse workers, are at increased risk of piCking up bacteria which 
originated from the animal. 
• 
• 
• 
There may be direct human to human spread of bacteria subsequent to human-
animal exposure. 
The consumption of meat, fish, vegetables or fruit that has been contaminated with 
animal feces or intestinal contents may disseminate bacteria to humans. 
People who drink or use water that has been contaminated may be exposed to 
bacteria. 
In 1997, the World Health Organization (WHO) showed concern over the excessive 
use of antibiotics in animals designated for human consumption as a growing risk to 
human health (WHO, 2001). Then in 1998, the European Union followed WHO 
recommendations by banning the use of antibiotics prescribed for animals that are also 
used as treatment for human infections and all antibiotic use for growth promotion in 
animals. Recent studies in Germany, Denmark and Switzerland indicate that the ban on 
avoparcin as a growth promoter is associated with a significant decrease in the prevalence 
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of vancomycin resistant enterococci in both poultry and humans (HealthCare Ontario, 
2001). 
The use of antibiotics in agriculture, as 'pesticides', is a common practice in many 
parts of Central and South America for prophylactic or therapeutic use against bacterial 
infections (Levy, 2001). In addition, the United States annually used approximately 
300,000 pounds of antibiotics, especially tetracycline and streptomycin, as pesticides in 
agriculture during the 1990's (Levy, 1992 and Harrison eta/., 1998). The use of antibiotics 
in agriculture increases the geographic spread of these drugs through the distribution of 
produce. Antibacterial pesticides are diluted as rain and other natural events disperse 
them through the environment, creating widespread selective pressure for the 
development of resistance (Levy, 2001 ). 
The primary contributor to antibiotic resistance is the use of these drugs in the 
community and hospital setting. The modem health care system is one in which health 
care professionals are overworked and under-informed about the problems of antibiotic 
resistance and are, therefore, often ill-equipped to deal with the large numbers of patients 
they encounter daily (WHO, 2001 ). Increased pressure often leads to misdiagnosis or 
unnecessary prescribing in an effort to prevent possible complications. It has been 
estimated that in North America physicians over-prescribe antibiotics by 50% (WHO, 
2001). Appropriate prescribing can also be difficult when the organism is not identified, or 
even identifiable by culture, and/or laboratory culture results are returned several days 
after the initial consultation. 
Add the pressure caused by patient demand to the basic pressures of our health 
care system and it creates quite a problem. Society seems to be suffering from a 'drug 
hunger'. Drug hunger has been described as the trend whereby patients are only 
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satisfied if a physician visit results in a prescription (Avom eta/., 2000). The desire for 
drugs as the primary solution to society's health problems has been fueled by 
television, internet, magazine and newspaper advertisements (WHO, 2001). Focus 
groups were held with pediatricians and family physicians in Atlanta, Georgia, in 1998, 
to discuss their attitudes regarding antibiotic prescribing (Barden eta/., 1998). Most 
physicians agreed that their prescribing could be decreased and that parental/patient 
expectation was the principle reason that influenced them to prescribe antibiotics. In a 
1997 study of physicians throughout Europe, they cited patient pressure as the number 
one reason why they prescribed the wrong antibiotics (WHO, 2001). 
Patients often believe that most infections, regardless of cause, can be 
successfully treated with antibiotics and thus expect to receive a prescription from their 
physician for any perceived infection (WHO, 2001). Many randomized, placebo-
controlled trials of acute bronchitis, cough and upper respiratory tract illnesses have 
shown that outcomes are similar between patients taking antibiotics and those given the 
placebo (Howie, 1976, Stott and West, 1976 and Brickfield eta/., 1986). However, of 
the patient-physician encounters for 'colds', upper respiratory tract infections and 
bronchitis in the United States in one year, 50% to 66% resulted in an antibiotic 
prescription (Gonzales eta/., 1997 and Metlay eta/., 1998). Certain patient 
demographic factors (female, young, white and residence in a rural area) are 
associated with an increased likelihood that antibiotics will be prescribed (Gonzales et 
a/., 1998). The use of antibiotic therapy when it is not warranted may create ideal 
conditions for the development of resistant organisms by creating an environment 
where resistance can be acquired through exposure to the drug or where naturally 
resistant organisms thrive. 
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The problem of resistance could be curbed by the appropriate and prudent use of 
antibiotics in both the community and agriculture. However, researchers need to 
determine the amount by which antibiotic use must be reduced and the extent to which a 
reduction in antibiotic consumption will affect antibiotic resistance in different 
microorganisms in order to establish guidelines that outline appropriate antibiotic use. 
There are several alanning trends in antibiotic prescribing patterns within Canada that 
should be noted, namely that children less than nine years of age receive proportionately 
more antibiotics than older individuals, family physicians write about 75% of all antibiotic 
prescriptions, antibiotics are often used to treat viral illnesses and second- and third-
generation drugs are overused in preference to simpler ones (Wang eta/., 1998). The 
most effective approach to prevention of transmission of drug resistant pathogens is 
preventing the initial emergence of resistance through selected and appropriate use of 
antibiotics (Jarvis, 1996). 
A wide variety of methods have been recommended for the improvement of 
antimicrobial use, including adherence to national or international guidelines, antimicrobial 
use evaluations, reporting of microbiology laboratory data to facilitate better antimicrobial 
use, antibiotic order fonns, automatic stop orders, educational programs and regulation of 
promotional efforts by phannaceutical representatives in the hospitals, etc. (Marr eta/., 
1988 and Jarvis, 1996). 
The selective role of antibiotic use relates not only to the total amounts being used, 
but also to how it is being used (Levy, 2001). Guillemot eta/. (1998) showed that when 
penicillin was given in less than therapeutic doses for relatively long periods of time (five 
days), the patient's risk of developing penicillin-resistant Streptococcus pneumoniae 
increased. However, when the drug was used at a higher dose for shorter periods of time, 
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the emergence of penicillin-resistant pneumococci was much lower. Therefore, it would 
appear that low-level, prolonged usage of antibiotics optimally selects for bacterial 
resistance. If this practice were to be avoided, there would be less selective pressure for 
antibiotic resistant organisms. 
The problem rests in the fact that the relationship between antibiotics and bacteria 
is not a simple one. It appears that in some geographic regions high antibiotic 
consumption does not lead to antibiotic resistance as rapidly as in other areas (Baquero, 
1996). Levy (2001) has stated that how an amount of antibiotic is distributed among 
individuals within a geographic area influences the frequency of antibiotic resistant 
bacteria. He suggests that giving 1000 doses of an antibiotic to one individual will have 
considerably less ecological effect on resistance emergence than giving the same 1 000 
doses to 1 000 individuals. This is referred to as the principle of selection density. 
Promotion of drug-resistant bacteria by antibiotics involves the number of individuals 
affected because they serve as the 'factories' of resistant bacteria and the density of these 
individuals in a particular environment. As the density of treated people increases, the 
number of resistant strains increases and ultimately, the number of susceptible strains 
able to survive in the environment decrease. However, in order to return to a normal 
ecology with susceptible microorganisms, an environment requires greater numbers of 
susceptible bacteria. 
Studies of newly emerging resistance show that resistance in bacteria primarily 
arises in steps progressing from low level to high level, unless a plasmid is acquired on 
which resistance is already present (Levy, 1998). Initially, penicillin resistant pneumococci 
appeared with slightly decreased susceptibility to penicillin but over time strains have 
evolved to a high level of resistance. Therefore, it is important to determine the level of 
-13-
- - -------- --------- -------
resistance in a population early enough to prevent the development of high level 
resistance in organisms. 
2.3 Current Research 
Mathematical models are being used as a means of studying the emergence and 
spread of resistant bacteria in both the hospital and community settings. Although the 
number and relationship between factors contributing to resistance are complex, 
mathematical models often only use a subset of factors which are thought to be of prime 
importance (Bonten eta/., 2001). These models use the volume of drug use as the 
primary selection pressure driving changes to the frequency of resistance in the 
community (Austin and Anderson, 1999). However, it is difficult to determine the precise 
quantitative relationship between antibiotic consumption and antibiotic resistance because 
of a lack of longitudinal studies which record both consumption and resistance patterns 
(Austin and Anderson, 1999). Instead, mathematical models allow an estimation of how 
altering various factors, such as population genetics, transmission dynamics and antibiotic 
consumption, will alter the development of resistance in the community. 
There has been a great deal of interest in determining the social, demographic and 
environmental factors which are contributing to the development and dissemination of 
resistant microbes globally. The main social factors which are contributing to resistance 
are poor patient compliance, excessive antibiotic usage in humans and animals and a lack 
of education regarding bacterial disease and antimicrobial therapy (Okeke eta/., 1999). 
These factors are common in both developing and industrialized countries. However, 
industrialized countries have more money and resources to combat the problem more 
effectively. Therefore, many wealthy countries have focused their efforts on fighting 
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infectious disease within their own borders, while failing to help eliminate them globally. 
However, bacteria, viruses, and parasites know no boundaries. They mutate elsewhere, 
become drug resistant and enter the wealthy countries via modern transportation, creating 
an international problem. This theory has generated much discussion throughout the 
world about the importance of surveillance schemes for antibiotic resistance. WHO 
(2001) now calls for surveillance of antibiotic resistance and antibiotic use at both local 
and national levels to guide clinical management and infection control, to monitor 
treatment guidelines, to update lists of essential drugs and to monitor the effectiveness of 
interventions to contain resistance. At the present time, there are no formal mechanisms 
or international documents that require reporting of resistance levels by individual 
countries. Instead, local and national resistance levels are identified through individual 
research projects that are published in scientific journals (WHO, 2001 ). Containing the 
problem of antibiotic resistance must involve cooperation between national governments 
and agencies, professional societies, non-governmental organizations and international 
agencies. 
A major problem with resistance research is determining which studies depict the 
most accurate picture of resistance in a community. Within the community, the 
association between the increasing prevalence of resistant organisms and the severity or 
duration of infection is much less obvious than in the hospital setting where it has been 
shown to increase mortality. 
There has been research directed at finding alternative forms of antimicrobial 
treatment (i.e., drugs, vaccines) against infections which have been shown to be caused 
by resistant microbes. However, bacteria are evolving at a much greater speed than new 
drugs are being developed. This is partially due to the fact that the pharmaceutical 
-15-
industry is very competitive and thus, some companies are not willing/able to spend the 
time, money and effort needed to develop new antibiotics when there is no guarantee of 
eventual profit (Culotta, 1994). The pharmaceutical industry has reported that the 
research and development of antimicrobial agents take 1 0 to 20 years and it costs a 
minimum of US$500 million to bring a single drug to market (WHO, 2001 ). There is also a 
lack of interest among companies in developing therapies for infections that primarily 
affect resource-poor regions of the world because of the limited potential to earn a profit 
(WHO, 2001). 
2.4 Antibiotic Susceptibility Testing Methodologies 
Susceptibility testing is preformed in the laboratory and does not necessarily reflect 
or predict in vivo efficacy. Susceptibility testing is subject to great variability depending on 
the pathogen tested, media used, conditions of incubation and method of accessing 
bacterial growth. The ability to detect the emergence and global spread of resistant 
organisms is hampered by the weakness, or total lack, of adequate surveillance of 
antimicrobial resistance (Cunha, 2000). Interpretation of existing surveillance data is 
hampered by the multiplicity of methods used to detect resistance and by difficulties in 
assessing the quality of the data. Even where good quality resistance surveillance data 
exist, they are frequently not translated into information for public health action. 
Two commonly used techniques which allow susceptibility profiles to be generated 
for various species of bacteria are disk diffusion and the E-test system. The agar disk 
diffusion method involves placing a disk impregnated with a specific concentration of 
antibiotic on an inoculated blood agar plate and then measuring the zone of inhibition 
between the middle of the disk and the edge of the bacterial growth with a ruler to 
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determine whether the organism is susceptible or resistant to the antibiotic. The zone of 
inhibition is measured in millimeters. 
The E-test system is a convenient and easy method for determining the minimum 
inhibitory concentration (MIC) of antibiotic to which bacterial isolates are susceptible. It 
consists of a reagent strip, which contains a continuous concentration gradient of antibiotic 
that diffuse into the agar onto which the organism has been inoculated. The MIC value is 
read from the point where the elliptical zone of inhibition intersects the E-strip and is 
measured in mcg/ml. It provides an in vitro method for quantitative antimicrobial 
susceptibility testing which is more expensive than the traditional methods. However, the 
E-test system has become quite popular in recent years because it combines the 
simplicity and flexibility of disk diffusion with the opportunity to determine MIC value of a 
specific antimicrobial agent for a particular bacterial isolate (Kiska eta/., 1995 and Murray, 
1995). 
MIC values are used as a measurement of antibiotic resistance and are defined as 
the drug concentration that prevents macroscopic growth after overnight incubation of the 
inoculated plates at 35 °C. The readings are always taken from the area where there is a 
complete inhibition of all growth, including hazes and isolated colonies. If there is no 
inhibition along the entire strip it is interpreted that the MIC is greater than the highest 
value on the scale. Likewise, if the inhibition zone is below the end of the strip, it is 
interpreted that the MIC is lower than the lowest value on t~~ scale. MIC value are 
interpreted using the National Committee for Clinical Laboratory Standards (NCCLS). 
NCCLS breakpoints (i.e., susceptible, intermediate and resistant) are based on achievable 
levels of antibiotic in the blood and the clinical data on response to treatment (NCCLS, 
1997). MIC50 and MIC90 are given to describe the MIC value for 50% and 90% of the 
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isolates tested, respectively. 
NCCLS categories of intermediate and resistant (sometimes referred to as high 
resistance) both refer to isolates which have decreased susceptibility to antibiotics. 
Strains with intermediate level resistance have MIC values which are 10 - 99 times greater 
and strains with high level resistance have MIC values which are 100-10,000 times 
greater than those for susceptible strains. 
When comparing methodologies, it is important to look at two measurements; 
sensitivity and specificity. Sensitivity is the ability of a test to identify which isolates are 
susceptible to an antibiotic while specificity refers to the ability to detect which isolates are 
resistant to an antibiotic. 
Several types of interpretative error may occur when comparing methodologies. A 
very major error is assumed to be present when a strain is classified as resistant by the 
reference method, such as theE-test system, and as susceptible by the method being 
tested (Chaves eta/., 1999). If the reverse scenario occurs, whereby the strain is 
classified as resistant by the method being tested and susceptible by the reference 
method, it is considered to be a major error (Chaves eta/., 1999). Finally, if a third 
susceptibility category (intermediate resistance) has been identified, a minor error may 
occur. A minor error is considered to be present when strains are either (I) classified as 
intermediate or resistant by the reference method and, respectively, as susceptible or 
intermediate by the method being tested or (ii) classified as intermediate or susceptible by 
the reference method and, respectively, as resistant or intermediate by the method being 
tested (Chaves eta/., 1999). 
Many recent studies of antibiotic resistance, especially in North America, use the E-
test methodology for determining susceptibility patterns since this system is more accurate 
-18-
than other testing techniques, such as disk diffusion (Lund eta/., 1998). Disk diffusion is 
sensitive, but not very specific and is generally considered acceptable as a screening test 
only. TheE-test system is much more specific and thus, can be used both as a 
surveillance tool in order to detect changing levels of resistance and to generate 
susceptibility profiles for bacteria which will be used to guide antibiotic use. However, the 
E-test system is also a very expensive tool. Each E-test strip costs approximately $1.00 
while each disk costs a few cents. In hospital laboratories, where many specimens must 
be tested daily to determine susceptibility patterns to a number of different antibiotics, the 
use of the E-test system is quite costly. Since susceptibility testing is such an important 
component of drug selection for the treatment of infections caused by S. pneumoniae, it is 
crucial that the methodology used be both accurate and financially viable. 
2.5 Drug resistant Streptococcus pneumoniae 
Streptococcus pneumoniae, bacteria which are also known as pneumococci, are 
gram-positive cocci that grow in chains and are catalase negative. They produce 
pneumolysin, a toxin that breaks down hemoglobin into a greenish degeneration product, 
thereby causing alpha hemolysis on blood agar. More than 98% of pneumococcal 
isolates are susceptible to optochin and virtually all pneumococcal colonies are dissolved 
by bile salts. Nearly every clinical isolate of pneumococcus has a polysaccharide capsule, 
resulting in 90 known distinct capsules. 
Pneumococci colonize the nasopharynx. and can be isolated from 5 to 1 0% of 
healthy adults and from 20 to 40% of healthy children (Harrison's Textbook of Medicine 
Online, 2003). Once the organisms have colonized an adult, they are likely to persist for 
two to four weeks but may persist for as long as six months. Pneumococci spread from 
-19-
one individual to another as a result of extensive close contact. For reasons that are 
unclear, certain populations, including Native Americans, Native Alaskans and African 
Americans, appear to be unusually susceptible to invasive pneumococcal disease 
(Harrison's Textbook of Medicine Online, 2003). 
Pneumococci attach to human nasopharygeal cells through the specific interaction 
of bacterial surface adhesions with epithelial cell receptors. Once the nasopharynx has 
been colonized, infection results if the organisms are carried into anatomically contiguous 
areas, such as the eustachian tubes or nasal sinuses, and if their clearance is hindered. 
The capacity to cause disease depends on two factors; 1) the ability of pneumococci to 
escape ingestion and killing by host phagocytic cells and 2) its ability to stimulate an 
inflammatory response and damage tissues. 
The first isolate of Streptococcus pneumoniae was collected 11 0 years ago 
(Jacobs, 1992). Since then, it has been recognized to be the leading cause of community-
acquired pneumonia and other infections, such as sinusitis, otitis media, meningitis and 
bacteremic septicemia (Tomasz, 1997). Infection with S. pneumoniae is the most 
common cause of potentially life-threatening, community acquired disease, such as 
meningitis and pneumonia. Each year in the United States, pneumococcal disease 
accounts for an estimated 3000 cases of meningitis, 50 000 case of bacteremia and 500 
000 cases of pneumonia (Reichler et a/., 1992 and Stool and Field, 1989). Each year in 
Canada, it accounts for 5000 cases of bacteremia, 700 000 cases of otitis media and 12 
500 cases of pneumonia resulting in hospitalization (Canadian Bacterial Surveillance 
Network, 2002). Before the discovery of antibiotics, the case-fatality rate for bacteremic 
pneumococcal pneumonia was greater than 75% (Tilghman and Finland, 1937). After the 
introduction of penicillin therapy for pneumococcal pneumonia, the case-fatality rate 
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dropped to 5% to 8% (Austrian, 1999). However, studies have recently shown that the 
case-fatality rate for bacteremic pneumococcal pneumonia ranges from 7% to 35% (Fine 
eta/., 1996, Kramer eta/., 1987, Ortqvisteta/., 1988, Afessa eta/., 1995, Marrie, 1992 
and Bruyn eta/., 1988). 
Within developed countries, invasive disease caused by this organism is a serious 
problem among the elderly, infants and those individuals with chronic underlying medical 
conditions (e.g., malignancy or human immunodeficiency virus) or immune systems that 
are compromised, either because of disease or immunosuppressive therapy. For patients 
who are immunodeficient, including those with HIV, the attack rate of pneumococcal 
infection is ten times that of the 'normal population' (Austrian, 1999). It has also been 
estimated that pneumococcal pneumonia results in the death of more than one million 
children each year in developing countries, approximately half of whom are less than one 
year of age (Buck eta/., 1999). 
Until recently, isolates of S. pneumoniae were uniformly susceptible to penicillin 
(Borek eta/., 1997). Pneumococci were considered to be among the most highly 
penicillin-susceptible bacteria noted throughout the first quarter-century of penicillin use 
(Tomasz, 1997). For example, during the 1940's, three of every four persons who were 
treated with penicillin survived when only a decade earlier, approximately four of every five 
persons died of pneumococcal pneumonia (Mufson, 1998). Therefore, penicillin was 
prescribed by physicians as 'the drug of choice' to combat pneumococcal infections. 
However, things started to change during the 1960's when the first strains of pneumococci 
with intermediate levels of penicillin resistance began to appear. 
Clinical pneumococcal resistance to penicillin was first recorded by researchers in 
Boston in 1965 when two of 200 strains showed minimum inhibitory concentrations (MICs) 
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within the intermediate resistance range (0.1 - 0.2 mcg/ml) (Appelbaum, 1992). However, 
the clinical significance of penicillin resistant S. pneumoniae was not appreciated until 
1967 when Hansman and Bullen recovered a resistant isolate (MIC 0.6 mcg/ml) from the 
sputum of a 25-year-old female patient with hypogammaglobulinemia and bronchiectasis 
in Australia. Another pneumococcal isolate showing a similar pattern of resistance was 
recovered from an aboriginal patient in Papua, New Guinea in the same year (Gold eta/., 
1996 and Tomasz, 1997). 
Regardless of where the first resistant isolate was identified, resistant strains 
appeared to spread rapidly through Australia and New Guinea during the 1960's, through 
South Africa in the 1970's and throughout countries in Africa, Asia and Europe during the 
1980's (Jernigan eta/., 1996). By the mid-1970's, highly resistant strains of pneumococci 
were being described elsewhere throughout the world (Gold eta/., 1996). In contrast to 
the first isolates which exhibited slightly elevated MIC values, the later strains were shown 
to have a dramatically increased MIC of penicillin as well as resistance to multiple 
antimicrobial agents, such as tetracycline, erythromycin, chloramphenicol, clindamycin, 
streptomycin and, in some cases, rifampin (Tomasz, 1997). The incidence of penicillin 
resistant S. pneumoniae increased during the succeeding years and continues to do so 
today. 
The development and progression of penicillin-resistant strains of S. pneumoniae 
primarily occur in the community setting while resistance in other organisms, such as 
vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus, initially 
emerged as nosocomial infections (Jacobs, 1999). It has been suggested that antibiotic 
resistance has probably emerged in the community as a result of a variety of factors 
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including; clustering and overcrowding, the increased number of immunocompromised 
patients, an increase in the number of elderly people in the population, increased travel, 
the widespread use of broad spectrum antibiotics, self treatment with antibiotics, the 
inappropriate use of antibiotics, a lack of compliance with treatment, fewer resources for 
in-service training of health workers, a lack of resources for infection control and 
decreased funding for public health surveillance. Emphasis has been placed on 
excessive selective pressure (i.e., overuse of antibiotics) and close exposure to carriers 
for being the major factors for acquiring drug-resistant S. pneumoniae (DRSP) (Klugman, 
1990). 
Many scientists have been trying to determine the current rates of penicillin 
resistance in North America and so far there have been a number of interesting results. A 
study of 845 respiratory tract isolates from 27 United States medical centers during the 
late 1990's showed an increase in the prevalence of penicillin resistant S. pneumoniae 
(PRSP) of 43.8% (Doorn eta/., 1998). The proportion of PRSP in the United States has 
jumped from 6.6% in 1991 - 1992 to 33.5% in 1996-1997 (Campbell and Silberman, 
1998). A similar trend has been noted for Canada where PRSP was uncommon in the 
1980's but has seen dramatic increases in recent years. The National Centre for 
Streptococcus in Edmonton noted an overall antibiotic resistance of 10.2% and a penicillin 
resistance of 7.6% for S. pneumoniae within Canada during 1996-1997 (Bucket a/., 
1999). Although rates of resistance for this organism have traditionally been higher in the 
United States than in Canada, it appears that such differences are decreasing as 
resistance continues to grow rapidly in Canada (Doorn eta/., 1998). Currently, there is no 
information on the rates of pneumococcal resistance in Newfoundland and labrador. 
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Drug resistant S. pneumoniae appears to be increasing in prevalence at an 
alarming rate. However, it is difficult to compare how the prevalence of resistant 
pneumococci is changing or whether there are meaningful differences between population 
groups because of methodologic differences in susceptibility testing between various 
regions and countries. New therapeutic strategies are needed to avoid further selection of 
the resistant strains that are colonizing and/or infecting patients, especially among 
pediatric populations. 
The Canadian Laboratory Centre for Disease Control (LCDC) guidelines released 
in 1998 stated that all S. pneumoniae isolates obtained from sterile body sites should be 
tested for antibiotic resistance. Sterile body sites include blood, cerebrospinal fluid, joint 
aspirates, pleural fluids, abscesses and any other site where there is clinical indication of 
a life-threatening infection. These isolates should be tested against penicillin (oxacillin), 
cefotaxime and/or ceftriaxone and vancomycin. The guidelines also stated that isolates 
from non-sterile sites do not require routine susceptibility testing (LCDC, 1998). However, 
they may be tested periodically to assess the degree of resistance of S. pneumoniae to 
various antibiotics commonly used to treat pneumococcal infections, such as penicillin 
(oxacillin), macrolides, cefuroxime, cefotaxime or ceftriaxone, co-trimoxazole, clindamycin 
or tetracycline. Incubation in C02 for the pneumococcal E-test improves the agreement 
with MIC results determined by NCCLS broth microdilution method and also, avoids the 
problem caused by the fact that some pneumococcal strains do not grow readily under 
ambient air incubation conditions (Jorgensen eta/., 1994). 
Antibiotics which may be prescribed for pneumococcal infections include penicillin, 
tetracycline, erythromycin, levofloxacin, ceftriaxone and meropenem. Penicillin belongs to 
the antibiotic group of the same name and is known to inhibit a number of bacterial 
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enzymes, namely penicillin binding proteins (PBPs), which are essential for bacterial 
peptidoglycan synthesis. Tetracycline also belongs to the antibiotic group of the same 
name and inhibits protein synthesis. Erythromycin belongs to the macrolide group of 
antibiotics. The macrolides inhibit bacterial RNA-dependent protein synthesis. 
Levofloxacin is a relatively new antibiotic and belongs to the quinolone group of drugs. 
The quinolones target DNA gyrase, an enzyme needed for bacterial DNA synthesis. 
Ceftriaxone is a third generation cephalosporin. This group is known to penetrate through 
the outer cell envelope of gram-negative organisms. Meropenem belongs to the 
carbapenem group of antibiotics. Like the penicillin drugs, this group binds to PBPs, 
causing cell elongation and lysis. 
The relationship between the frequency and type of antibiotic usage and the 
prevalence of pneumococcal penicillin resistance is well recognized and prescription 
patterns are closely linked with resistance trends (Baquero, 1996). During a 1992-1993 
study of antibiotic resistance and antibiotic consumption within five countries of the 
European Union and the United States, it was shown that the lowest rates of Beta-lactam 
prescription occurred in Germany and Italy which had the lowest levels of penicillin 
resistant S. pneumoniae while the highest consumption and resistance levels occurred in 
Spain and France (Baquero, 1996). This illustrates the importance of studying the levels 
of antibiotic consumption within the community when looking at the levels of 
pneumococcal resistance within a population. 
Baquero (1996) also showed that there are other factors which are associated with 
antibiotic resistant pneumococci in a population. While the prescription rates of 
aminopenicillins and Beta-lactams in the United Kingdom approached that of France and 
were higher than that of the United States, the level of penicillin resistance in the United 
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Kingdom was lower than that of both these countries. Therefore, the selective effect of 
antibiotic consumption on antibiotic resistant S. pneumoniae may also be dependent on 
the structure and density of the different populations present at a given moment in a 
particular area (Baquero, 1996). 
In 1945, Macleod, Hodges, Heidelberger and Bernhard reported that purified 
pneumococcal capsular polysaccharides were effective in preventing pneumococcal 
infections (Macleod eta/., 1945). They found that if one were a carrier of a 
pneumococcal strain that was contained in the vaccine, immunization would not eliminate 
the carrier state. However, if a person were not a carrier before vaccination, the likelihood 
of becoming one after vaccination was reduced by half. A 23-valent polysaccharide 
pneumococcal vaccine, known as Pneumovax™, has been available for commercial use 
since the 1980s. The polysaccharide antigens are used to induce type-specific antibodies 
that enhance killing of pneumococci by phagocytic cells. 
As indicated in 1945, the polysaccharide pneumococcal vaccine appears to reduce 
carriage and the spread of S. pneumoniae (McCormick, 1998). Many antibiotic resistant 
pneumococcal isolates belong to one of the 23 capsular types contained in the vaccine 
(Rossi eta/., 1997, Dagan eta/., 1996, Hortal eta/., 1997 and luey and Kim, 1996). 
In the early 1990s, it was estimated that 40,000 people died annually in the United 
States from pneumococcal infections which were vaccine preventable (Gardner and 
Schaffner, 1993). This was partially due to the fact that polysaccharide vaccines are not 
immunogenic in children less than two years of age which rendered Pneumovax™ useless 
in this age group. Then in 2000, a protein conjugate pneumococcal vaccine, known as 
Prevnar™, was introduced. Prevnar™ was aimed at reducing the incidence of invasive 
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pneumococcal disease in children. The conjugated pneumococcal vaccine elicits aT-cell 
dependent memory response and protects against seven common serotypes. 
Currently, Prevnar™ is considered the vaccine of choice in children while 
Pneumovax™ is widely used in the adult population. Successful vaccination is indicated 
by a twofold antigen-specific antibody response within two to three weeks after receiving 
the injection. 
2.6 Objectives 
There has been limited research into the problem of pneumococcal antibiotic 
resistance or community antibiotic use in the province of Newfoundland and Labrador. 
This research project is intended to provide the baseline data regarding the level of 
antibiotic resistance of Streptococcus pneumoniae and antibiotic consumption for the 
province of Newfoundland and Labrador. The objectives of this project are to: 
1.) To describe the resistance levels of Streptococcus pneumoniae within the different 
regions of Newfoundland and Labrador. 
2.) To determine the relationship between various factors, including specimen source, 
patient age, patient sex and population density, and antibiotic resistance. 
3.) To compare the accuracy of disk diffusion versus E-test methodology. 
4.) To describe the trends in antibiotic consumption within Newfoundland and 
Labrador. 
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3.0 MATERIALS AND METHODS 
3.1 Protocol 
This research project began as a part of the existing 'Optimal Antibiotic Project' 
which had been granted ethical approval by the Human Investigations Committee at 
Memorial University if Newfoundland. The Optimal Antibiotic Project began in 1997 and 
was designed to measure resistance in bacteria, measure antibiotic use and measure 
health care resource use related to community acquired infections (Appendix C). 
Ten hospital laboratories throughout the island portion of the province of 
Newfoundland and Labrador were invited to participate in this project at a meeting held 
with the laboratory directors. The sites which participated in this study included St. John's, 
Clarenville, Gander, Grand Falls, Corner Brook, Burin, Carbonear, Placentia and 
Stephenville. Laboratory selection was based on geographical location, thereby ensuring 
that the isolates would be received within several days in order to maintain viability of the 
organisms. For this reason pneumococcal isolates from laboratories in Labrador and St. 
Anthony were not included in this study. 
Pneumococcal isolates from each of the sites were sent to the Provincial Public 
Health Laboratory (PHL), using a standard protocol already established by the PHL 
(Appendix A). The susceptibility testing of all clinically significant pneumococcal isolates 
began in January 1, 2000 and was completed in December 31, 2000. Clinically significant 
isolates were defined as those either from normally sterile sites (i.e., cerebrospinal fluid 
and blood) or from specimens that made contact with mucosal surfaces (i.e., sputum). 
The number of isolates tested was dependent on the number submitted by the 
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participating laboratories. The PHL annually receives approximately 80 isolates in total 
from the participating laboratories. However, the anticipated sample size for this study 
was 1 00 isolates. 
Patients' sex, age, specimen site and geographic location were recorded. 
Surveillance swabs were excluded, as were duplicates of isolates. Surveillance swabs are 
isolates that are taken specifically to detect the level of resistance in S. pneumoniae and 
are not clinically important for the treatment of an individual. Since surveillance swabs are 
not clinically significant they were eliminated from this study. Each isolate was given an 
identification number at the PHL which prevented any means of identifying the patient 
directly. 
Once a bacterial isolate was submitted to the hospital laboratory, it became the 
property of that facility, thereby eliminating the need to request permission from the patient 
to use the specimen for research purposes. Instead, permission to use the pneumococcal 
isolate was granted by the director of the laboratory. 
Each isolate was identified as S. pneumoniae at each participating lab based on its 
susceptibility to optochin prior to being sent to the PHL. S. pneumoniae has maintained 
uniform susceptibility to optochin. Therefore, in the laboratory setting an organism is 
identified as pneumococcus if it is susceptible to the drug. 
3.2 Antibiotic Sensitivity Testing 
Susceptibility testing was performed at the PHL. All isolates were tested by both 
systems described above for their sensitivity to the following antibiotics; penicillin, 
tetracycline, erythromycin and levofloxacin. If an isolate was shown to be resistant to 
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penicillin, its susceptibility was tested to ceftriaxone and meropenem. Bacterial 
suspensions were prepared in trypticase soy broth (TSB) using cultures grown under 5 % 
C02 at 35 - 36 oc on sheep blood agar (BA) plates (Appendix B). The turbidity of the 
suspension was adjusted to a 0.5 McFarland density standard in sterile saline or to a 1.0 
McFarland standard if the isolate was mucoid. Within 15 minutes of the preparation, the 
inoculum was unifonnly spread on fresh BA plates by using a sterile swab and the plates 
were allowed to dry for 1 0 - 15 minutes before applying the strips and disks. Each plate 
prepared contained a disk and E-strip containing the same antibiotic as a quality control 
measure. All plates were then incubated at 35 °C in 5 % C02 for 16 - 18 hours. 
The oxacillin screen was also used as an indicator of penicillin resistance. Isolates 
with an oxacillin zone diameter greater than 20 mm are considered to be susceptible to 
penicillin and no further testing is done. However, a zone diameter of less than 20 mm 
does not always indicate penicillin resistance and requires further testing, in order to 
determine the specific MIC. 
3.3 Antibiotic Utilization 
lnfonnation on antibiotic use was collected from all outpatient pharmacies in 
Newfoundland using the structure developed by IMS HEALTH Canada. The infonnation 
generated by this organization was expressed in the number of prescriptions filled within 
the province. IMS HEALTH was established in 1960 and currently serves as a leading 
source of infonnation regarding the Canadian health care system. In addition to a variety 
of products and services provided by IMS HEALTH Canada, it also monitors antibiotic 
prescription activity by regular CompuScript audits. The IMS prescription database panel 
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is comprised of 4,400 pharmacies, which amounts to approximately two-thirds of all retail 
pharmacies in Canada. Of these phannacies, 2,1 00 stores make up the CompuScript 
panel which then, provide monthly records of their prescription activity. This data can then 
be used to generate information regarding the trends in prescribing for a variety of drugs, 
including antibiotics, based on a classification system established by IMS HEALTH. 
The internationally accepted fonnat for describing antibiotic consumption is the 
World Health Organizations Anatomical Therapeutic Classification (ATC) System in 
Defined Daily Doses (ODDs). The ODD is defined as the assumed average maintenance 
dose per day for a drug used on its main indication in adults. Prescription data monitored 
and presented in ODDs provide only an estimate of consumption and not an exact picture 
of actual use. Instead, this system is considered to be a phannacoepidemiological tool 
which may be used to measure, analyze and influence the use of drugs and to detect 
changes over time. The ATC/DDD System allows comparisons between different settings, 
regions or even countries, which is also independent of sales prices and package size. 
Although the ATC/DDD System is the preferred method for describing antibiotic 
consumption, IMS HEALTH Canada continues to generate pharmaceutical infonnation in 
number of prescriptions filled. Therefore, this study will analyze how much antibiotic was 
actually consumed by the Newfoundland population through the number of prescriptions 
filled. 
3.4 Statistical Analysis 
Statistical analysis was performed with SPSS (Version 8) and Microsoft Excel. 
Descriptive statistics were used to compare susceptibility profiles based on region, patient 
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age, patient sex and specimen source. Crosstabulations were used to detect isolates 
which exhibited multiple resistance. The antibiotic use information was compared for the 
different drugs of interest over a four year period. 
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4.0 RESULTS 
4.1 Patient Demographics 
There was a total of 83 isolates of S. pneumoniae submitted for this study between 
January 1 and December 31, 2000. Three of these isolates were submitted to the PHL 
without the appropriate patient and regional information and thus, had to be excluded from 
the demographic analysis. Therefore, 80 isolates were obtained with all or some of the 
appropriate demographic information. Of these, six isolates lacked information regarding 
the patienfs sex, eight isolates lacked information on the source from which the specimen 
was taken, three lacked information on the region from where it was collected and four 
isolates lacked information on the age of the patient. However, all 83 isolates were used 
in the comparison of the two antibiotic resistance testing methodologies. 
The regional distribution of 77 pneumococcal isolates included in this study is 
shown in Table 1. The greatest portion of isolates tested was submitted by the Health 
Care Corporation of St. John's (n = 54, 70.1 %), followed by the Central West Health 
Corporation (n = 12, 15.6%). Table 1 also shows that the Central East Health Care 
Institutions Board and the Western Health Care Corporation submitted four isolates 
(5.2%) each, two isolates were obtained from the Peninsulas Health Care Corporation 
(2.6%) and one isolate was submitted by the Avalon Health Care Institutions Board 
(1.3%). 
Due to the small number of pneumococcal isolates received from hospitals outside 
of St. John's, further analysis of the demographic data was considered on the basis of 
their location in relation to St. John's (i.e., hospital laboratories within St. John's 
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Table 1 : Regional distribution of isolates used to detennine the antibiotic susceptibility 
pa tt f S . with. N ~ dl d f J 1 t D b 31 2000 ernso .pneumomae In e oun an rom anuary 0 ecem er I 
Region Frequency Percent(%) 
Health Care Corporation of 54 70.1 
St. John's 
Avalon Health Care 1 1.3 
Institutions Board 
Peninsulas Health Care 2 2.6 
Corporation 
Central East Health Care 4 5.2 
Institutions Board 
Central West Health 12 15.6 
Corporation 
Western Health Care 4 5.2 
Corporation 
TOTAL 77 100 
-34-
r-- -------- --------------- -------
or outside of St. John's). Table 2 shows the distribution of isolates on the basis of patient 
age, sex and specimen source in relation to the geographic location of the laboratory from 
which they were obtained. Higher proportions of pneumococcal isolates were retrieved 
from children and senior citizens than other adults and non-sterile site sources 
predominated in both locations (Table 2). The number of isolates retrieved from males 
and females was approximately equal (Table 2). 
4.2 Methodology Analysis 
When comparing the two methodologies (disk diffusion versus E-test) used for 
susceptibility testing in this study, the E-test system was considered to be the 'gold 
standard'. Table 3 compares the use of oxacillin disks versus penicillin E-test strips for 
detennining pneumococcal susceptibility to penicillin. The disk diffusion system classified 
65 isolates as penicillin susceptible and 18 isolates as being penicillin resistant while the 
penicillin E-strips identified 64 isolates as susceptible and 19 as resistant (Table 3). One 
minor error was present since one isolate was identified as having intennediate resistance 
by E-test and susceptible by disk diffusion. Oxacillin disks have a sensitivity of 100% and 
a specificity of 94.7%. 
Table 4 compares the use of disk diffusion versus E-test for detennining 
pneumococcal susceptibility to erythromycin. The erythromycin disks categorized 79 
isolates as being antibiotic susceptible and four as resistant. However, when the same 
isolates were tested using erythromycin E-strips (gold standard), 78 isolates were 
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Table 2: Distribution of isolates used to determine the antibiotic susceptibility patterns of 
S. pneumoniae within Newfoundland from January 1 to December 31, 2000 on the basis 
f h. I f d . o geograp 1c oca 1on, age, sex an specimen source. 
FACTOR GEOGRAPHIC LOCATION TOTAL(%) 
St. John's Outside St. John's 
Age 
=/<18 (Pediatric) 18 10 28 (36.8) 
19-49 (Adult) 11 5 16 (21 .1) 
=/>50 (Elderly) 24 8 32 (42.1) 
76 
Specimen Source 
Sterile 17 1 18 (25.0) 
Non-sterile 36 18 54 (75.0) 
72 
Sex 
Male 23 12 35 (47.3) 
Female 28 11 39 (52.7) 
74 
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T able 3: c f omparison o surveillance methodologies used to detect penicillin resistance. 
E-test Susceptible 
Disk Susceptible 64 
Disk Resistant 0 
Total 64 
Sensitivity = 64 = 1 00% 
64 
E-test Resistant 
1 
18 
19 
Specificity= __11l = 94.7% 
19 
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Total 
64 
18 
83 
Table 4: Comparison of surveillance methodologies used to detect erythromycin 
resistance. 
E-test Susceptible 
Disk Susceptible 78 
Disk Resistant 0 
Total 78 
Sensitivity = 78 = 1 00% 
78 
E-test Resistant 
1 
4 
5 
Specificity = A_ = 80.0% 
5 
-38-
Total 
79 
4 
83 
.--------------------------------~-------~-
classified as antibiotic susceptible and five isolates were classified as having high 
resistance to erythromycin (Table 4). A very major error was present since the 
erythromycin E-test identified one isolate as being resistant while disk diffusion classified it 
as susceptible. The erythromycin disks had a sensitivity of 1 00% and a specificity of 
80.0%. 
Table 5 compares the use of disk diffusion versus E-test for determining 
pneumococcal susceptibility to tetracycline. Using the tetracycline disks, 81 isolates were 
categorized as being antibiotic susceptible and two were resistant. However, using 
tetracycline E-strips, 80 isolates were classified as antibiotic susceptible and three isolates 
were classified as being resistant. Of the three resistant isolates, one was defined as 
having intermediate resistance and two were classified as having high resistance to 
tetracycline. A single minor error was present since the tetracycline E-test identified one 
isolate as intermediate and disk diffusion identified it as susceptible. The tetracycline 
disks have a sensitivity of 100% and a specificity of 66.7%. 
4.3 Susceptibility Profile Analysis 
Table 6 summarizes the overall levels of resistance detected in the pneumococcal 
isolates analyzed during this study. The greatest level of resistance was seen toward 
penicillin with 77.1% (n = 64) being susceptible and 22.9% (n = 19) having intermediate 
resistance (Table 6). Tetracycline was the only antibiotic tested to which both 
intermediate (n = 1, 1.2%) and high (n = 2, 2.4%) resistance was seen (Table 6). Only five 
isolates (6.0%) were classified as having high resistance to erythromycin and one (1.2%) 
was classified as having high resistance to levofloxacin (Table 6). No resistance was 
detected 
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t tetrac cline resistance. Table 5: Comparison of surveillance methodologies used to detec 
E-test Susceptible E-test Resistant Total 
Disk Susceptible 80 1 81 
Disk Resistant 0 2 2 
Total 80 3 83 
Sensitivity = 80 = 1 00% Specificity = _l_ = 66. 7% 
80 3 
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Table 6: Susceptibility profile of all isolates as indicated by theE-test system received 
during the study period (January 1, 2000 to December 31, 2000 
Antibiotic Frequency - Number(%) Total 
Susceptible Intermediate Resistant 
Penicillin 64 (77.1) 19 (22.9) - 83 
Tetracycline 80 (96.4) 1 (1.2) 2 (2.4) 83 
Erythromycin 78 (94.0) - 5 (6.0) 83 
Levofloxacin 82 (98.8) - 1 (1.2) 83 
Ceftriaxone 19 (100) - - 19 
Meropenem 19 (100) - - 19 
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toward ceftriaxone or meropenem. 
Of the 54 isolates received from the Health Care Corporation of St. John's, 46 
(85.2%) were penicillin susceptible while eight (14.8%) had intermediate resistance to 
penicillin (Table 7). There were 52 isolates (96.3%) classified as being susceptible and 
two (3.7%) with high resistance to tetracycline (Table 7). There were also 51 isolates 
(94.4%) with erythromycin susceptibility and three isolates (5.6%) with high resistance to 
erythromycin (Table 7). All of the isolates submitted by the Health Care Corporation were 
shown to be susceptible to levofloxacin, ceftriaxone and meropenem. 
Of the 23 isolates received from the participating laboratories outside of the Health 
Care Corporation of St. John's, 13 (56.5%) were penicillin susceptible while 10 (43.5%) 
had intermediate resistance to penicillin (Table 8). There were 22 isolates (95.7%) 
classified as being susceptible and one (4.3%) with high resistance to tetracycline (Table 
8). There were also 22 isolates (95.7%) with erythromycin susceptibility and one isolate 
(4.3%) with high resistance to erythromycin (Table 8). All of the isolates were susceptible 
to levofloxacin, ceftriaxone and meropenem. 
Table 9 shows the susceptibility profile of the 20 isolates obtained from sterile sites. 
Of these isolates, 17 (85.0%) were penicillin susceptible and three (15.0%) had 
intermediate resistance to penicillin. When looking at erythromycin susceptibility, 19 
(95.0%) were susceptible and one (5.0%) had high resistance. None of the 
pneumococcal isolates was shown to have resistance to tetracycline, levofloxacin, 
ceftriaxone or meropenem. 
Table 1 0 shows the susceptibility profile of the 55 isolates obtained from non-sterile 
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Table 7: Susceptibility profile of isolates received from the Health Care Corporation of St. 
John's 
Antibiotic Frequency - Number (%) Total 
Susceptible Intermediate Resistant 
Penicillin 46 (85.2) 8 (14.8) - 54 
Tetracycline 52 (96.3) - 2 (3.7) 54 
Erythromycin 51 (94.4) - 3 (5.6) 54 
levofloxacin 54 (100) - - 54 
Ceftriaxone 8 (100) - - 8 
Meropenem 8 (100) - - 8 
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Table 8: Susceptibility profile of isolates received from hospital laboratories outside of St. 
John's 
Antibiotic Frequency - Number (%) Total 
Susceptible Intermediate Resistant 
Penicillin 13 (56.5) 10 (43.5) - 23 
Tetracycline 22 (95.7) - 1 (4.3) 23 
Erythromycin 22 (95.7) - 1 (4.3) 23 
Levofloxacin 23 (100) - - 23 
Ceftriaxone 10 (100) - - 10 
Meropenem 10 (100) - - 10 
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Table 9: Susceptibility profile of isolates received from sterile sites 
Antibiotic Frequency - Number (%) Total 
Susceptible Intermediate Resistant 
Penicillin 17 (85.0) 3 (15.0) - 20 
Tetracycline 20 (100) - - 20 
Erythromycin 19 (95.0) - 1 (5.0) 20 
Levofloxacin 20 (100) - - 20 
Ceftriaxone 3 (100) - - 3 
Meropenem 3 (100) - - 3 
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sites. Of these isolates, 43 (78.2%) were penicillin susceptible and 12 (21.8%) had 
intermediate resistance to penicillin. Tetracycline resistance was found in three isolates 
(one had intermediate resistance and two were highly resistant). There were 52 isolates 
(94.5%) identified as being susceptible and three (5.5%) had high resistance to 
erythromycin. There was also one isolate (1.8%) which was resistant to levofloxacin. 
None of the pneumococcal isolates was shown to have resistance to ceftriaxone or 
meropenem. 
Table 11 shows the susceptibility profile of the 29 isolates obtained from pediatric 
patients. Of these isolates, 24 (82.8%) were penicillin susceptible and five (17.2%) had 
intermediate resistance to penicillin. None of the pneumococcal isolates was shown to 
have resistance to tetracycline, erythromycin, levofloxacin, ceftriaxone or meropenem. 
Table 12 shows the susceptibility profile of the 17 isolates obtained from adult 
patients. Of these isolates, 13 (76.5%) were penicillin susceptible and four (23.5%) had 
intermediate resistance to penicillin. There was one isolate (5.9%) with intermediate 
resistance and one (5.9%) with high resistance to tetracycline. High resistance to 
erythromycin was indicated in four isolates (23.5%). None of the pneumococcal isolates 
was shown to have resistance to levofloxacin, ceftriaxone or meropenem. 
Table 13 shows the susceptibility profile of the 33 isolates obtained from elderly 
patients. Of these isolates, 23 (69.7%) were penicillin susceptible and ten (30.3%) had 
intermediate resistance to penicillin. There was one isolate (3.0%) which had resistance 
to tetracycline. None of the pneumococcal isolates was shown to have resistance to 
erythromycin levofloxacin, ceftriaxone or meropenem. 
Table 14 shows the susceptibility profile of the 37 isolates obtained from males. Of 
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Table 10: Susceptibility profile of isolates received from non-sterile sites 
Antibiotic Frequency - Number (%) Total 
Susceptible Intermediate Resistant 
Penicillin 43 (78.2) 12(21 .8) - 55 
Tetracycline 52 (94.5) 1 (1.8) 2 (3.7) 55 
Erythromycin 52 (94.5) - 3 (5.5) 55 
Levofloxacin 54 (98.2) - 1 (1.8) 55 
Ceftriaxone 12 (100) - - 12 
Meropenem 12 (100) - - 12 
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Table 11 : Susceptibility profile of isolates received from pediatric patients ( 18 years or 
vounger) 
Antibiotic Frequency - Number (%) Total 
Susceptible Intermediate Resistant 
Penicillin 24 (82.8) 5 (17.2) - 29 
Tetracycline 29 (100) - - 29 
Erythromycin 29 (100) - - 29 
Levofloxacin 29 (100) - - 29 
Ceftriaxone 5 (100) - - 5 
Meropenem 5 (100) - - 5 
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Table 12: Susceptibility profile of isolates received from adult patients (19- 49 years) 
Antibiotic Frequency - Number (%) Total 
Susceptible Intermediate Resistant 
Penicillin 13 (76.5) 4 (23.5) - 17 
Tetracycline 15 (88.2) 1 (5.9) 1 (5.9) 17 
Erythromycin 13 (76.5) - 4 (23.5) 17 
Levofloxacin 17 (100) - - 17 
Ceftriaxone 4 (100) - - 4 
Meropenem 4 (100) - - 4 
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Table 13: Susceptibility profile of isolates received from elderly patients (50 years or 
greater) 
Antibiotic Frequency • Number (%) Total 
Susceptible Intermediate Resistant 
Penicillin 23 (69.7) 10 (30.3) - 33 
Tetracycline 32 (97.0) - 1 (3.0) 33 
Erythromycin 33 (100) - - 33 
Levofloxacin 33 (100) - - 33 
Ceftriaxone 10 (100) - - 10 
Meropenem 10 (100) - - 10 
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these isolates, 28 (75.7%) were susceptible and nine (24.3%) had intermediate resistance 
to penicillin. Thirty-five (94.6%) were susceptible and two (5.4%) had intermediate 
resistance to tetracycline. There were 36 isolates (97.3%) identified as being susceptible 
and one (2.7%) had intermediate resistance to erythromycin. None of the pneumococcal 
isolates was shown to have resistance to levofloxacin, ceftriaxone or meropenem. 
Table 15 shows the susceptibility profile of the 40 isolates obtained from females. 
Of these isolates, 30 (75.0%) were penicillin susceptible and ten (25.0%) had intermediate 
resistance to penicillin. When looking at tetracycline resistance, 39 (97.5%) were 
susceptible and one (2.5%) had high resistance. There were 37 isolates (92.5%) 
identified as being erythromycin susceptible and three (7 .5%) had high resistance to 
erythromycin. None of the pneumococcal isolates was shown to have resistance to 
levofloxacin, ceftriaxone or meropenem. 
Table 16 illustrates the MIC50 and MIC90 for each of the antibiotics tested. The 
MIC50 for penicillin is 0.0012 mcg/ml, indicating the MIC at which 50% of the isolates 
were inhibited, while the MIC90 is 0.5000 mcg/ml, indicating the MIC at which 90% of the 
isolates were inhibited. For the penicillin E-test system, 0.0012 mcg/ml is classified as 
antibiotic susceptible and 0.5000 mcg/ml is indicative of intermediate level resistance. 
The MIC50 and MIC90 for ceftriaxone are 0.1900 mcg/ml and 0.5000 mcg/ml, respectively. 
These two values indicate that both 50% and 90% of the isolates were inhibited at MICs 
categorized as antibiotic susceptible for ceftriaxone. 
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Table 14: Susceptibility profile of isolates received from males 
Antibiotic Frequency - Number (%) Total 
Susceptible Intermediate Resistant 
Penicillin 28 (75.7) 9 (24.3) - 37 
Tetracycline 35 (94.6) 2 (5.4) - 37 
Erythromycin 36 (97.3) 1 (2.7) - 37 
Levofloxacin 37 (100) - - 37 
Ceftriaxone 8 (100) - - 8 
Meropenem 8 (100) - - 8 
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Table 15: Susceptibility profile of isolates received from females 
Antibiotic Frequency - Number(%) Total 
Susceptible Intermediate Resistant 
Penicillin 30 (75.0) 10 (25.0) - 40 
Tetracycline 39 (97.5) - 1 (2.5) 40 
Erythromycin 37 (92.5) - 3 (7.5) 40 
Levofloxacin 40 (100) - - 40 
Ceftriaxone 10 (100) - - 10 
Meropenem 10 (100) -
- 10 
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T bl 16 C a e f th MIC t h. h 50% d 90% f th . I t ompanson o e saw 1c o an oO e 1so a es were 1n 1 1 e 
Antimicrobial Agent MIC50 (mcg/ml) MIC90 (mcg/ml) 
Penicillin 0.0012 0.5 
Ceftriaxone 0.19 0.5 
Erythromycin 0.125 0.19 
Meropenem 0.19 0.25 
Tetracycline 0.125 0.25 
Levofloxacin 0.75 1 
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The MIC50 and MIC90 for erythromycin are 0.1250 mcg/ml and 0.1900 mcg/ml, 
respectively, indicating that 50% and 90% of the isolates were inhibited at MICs 
categorized as antibiotic susceptible for this antibiotic. The MIC50 and MIC90 for 
tetracycline are 0.1250 mcg/ml and 0.2500 mcg/ml, respectively. Both MIC values 
indicate that 50% and 90% of the isolates were inhibited at MICs categorized as antibiotic 
susceptible to tetracycline. The MIC50 and MIC90 for meropenem are 0.1900 mcg/ml and 
0.2~ mcg/ml, respectively, indicating that 50% and 90% of the isolates were inhibited at 
MICs categorized as antibiotic susceptible for meropenem. The MIC50 and MIC90 for 
levofloxacin is 0.7500 and 1.0000, respectively, thereby identifying that 50% and 90% of 
the isolates were inhibited at MICs categorized as antibiotic susceptible for levofloxacin. 
Resistance to multiple antibiotics was demonstrated in some isolates in this study. 
Of the 19 isolates which were categorized as having intermediate resistance to penicillin, 
one isolate was also shown to have intermediate resistance to tetracycline, two had high 
resistance to tetracycline and three were resistant to erythromycin. Of the five isolates 
which were resistant to erythromycin, two were also resistant to tetracycline (one was 
classified as being intermediate and one was highly resistant). 
4.4 Total Antibiotic Consumption Analysis 
Figure 1 shows the rates of antibiotic prescription per 1000 people per day in 
Newfoundland and Labrador for a four year period. During the study period, penicillins 
were the most commonly used antibiotics. The rate of penicillin prescription steadily 
declined from 1.685 prescriptions per 1000 people per day in 1997 to 1.373 in 2000. Use 
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Figure 1: Newfoundland antibiotic prescription rates from 1997 to 2000 
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of tetracycline and trimethoprim drugs also decreased during the study period. 
Tetracycline use decreased from 0.155 prescriptions per 1000 people per day in 1997 to 
0.131 in 2000 while trimethoprim use dropped from 0.475 prescriptions per 1000 people 
per day in 1997 to 0.37 4 in 2000. 
The only class of antibiotics which increased in rate of consumption during the four 
year study period were the quinolones (Figure 1 ). The rate of quinolone use increased 
from 0.246 prescriptions per 1000 people per day in 1997 to 0.273 in 2000. 
The use of macrolide and cephalosporin drugs fluctuated during this period (Figure 
1 ). Cephalosporin use declined from 0.472 prescriptions per 1000 people per day in 1997 
to 0.376 in 1999 and then increased to 0.387 prescriptions per 1000 people per day in 
2000. However, macrolide use dropped from 0.412 prescriptions per 1000 people per day 
in 1997 to 0.353 in 1998, then increased to 0.376 prescriptions per 1000 people per day in 
1999, only to decrease again in 2000. 
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5.0 DISCUSSION 
As we begin the twenty-first century, one of the most important public health issues 
facing society is the increasing threat of untreatable bacterial infectious diseases, 
especially those which exhibit antibiotic resistance. Many people fear that we are on the 
verge of a 'medical disaster' that would return society to the pre-antibiotic days when even 
small infections could become life-threatening due to a lack of effective treatments. 
Newfoundland is the perfect environment in which to study changes in antibiotic 
resistance. It is relatively easy to collect and collate information on virtually all of the 
approximately 500,000 inhabitants of this province. Also, the population of Newfoundland 
is relatively isolated and as such, we may assume that changes in resistance rates are 
due to factors present within this environment rather than those introduced into it. 
Although this may change in the near future with the increased interest in the oil industry 
off the Newfoundland coast and people going to mainland Canada for work and returning 
for visits. 
Newfoundland presents an interesting case when it comes to the issue of antibiotic 
resistance. As mentioned previously, the level of antibiotic resistance within a population 
is a function of its antibiotic consumption. However, within this province, the overall rates 
of resistance among clinical isolates remains relatively low despite high rates of antibiotic 
consumption by the people of Newfoundland. This implies that factors other than human 
consumption, such as population density, may be involved in the genesis and sustenance 
of antibiotic resistance within this province. It is difficult to verify this theory since there is 
limited data regarding antibiotic resistance levels within St. John's and no data for the rest 
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of the province. 
5.1 Patient Demographics and Susceptibility Profiles 
The number of isolates tested during this study (n = 83) was consistent with the 
annual number of pneumococcal isolates received by the PHL (n = 80) for routine 
susceptibility testing (Table 1). 
The results of this study show that 22.9% of isolates tested were identified as 
having intermediate levels of resistance to penicillin (MICs, 0.12 - 1 mcg/ml) (Table 5). 
We had anticipated that the information collected during this study might indicate low 
levels of pneumococcal resistance within Newfoundland. Although this number appears 
to be somewhat higher than anticipated for Newfoundland, data generated during a 
SENTRY antimicrobial resistance surveillance program of seven Canadian institutions in 
1997 showed that of the pneumococcal isolates tested 69.2% were susceptible, 21 .8% 
were intennediate and 8.4% were highly resistant to penicillin (Doern eta/., 1998). It has 
also been shown that the pattern of resistance is not unifonn across Canada (Biondeau et 
a/., 1999). Instead, resistance rates appear to increase from East to West. From the 
limited information here, however, the levels of intermediate resistance to penicillin in this 
study are comparable to the levels of resistance elsewhere in Canada. 
The levels of resistance to the other antibiotics tested during this study were much 
lower than that of penicillin. Approximately 3.6% (1 .2% with intermediate and 2.4% with 
high resistance) of isolates were shown to have decreased susceptibility to tetracycline 
(Table 5). In a study of 202 respiratory tract isolates obtained from seven hospitals across 
Canada, 10.2% of pneumococcal isolates in Canada were shown to be resistant to 
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tetracycline (Doern eta/., 1998), comparatively higher than the results of this study. 
Only 1.2% of isolates were highly resistant to levofloxacin (Table 5). The incidence 
of quinolone resistance is generally thought to be fairly low, less than 5% (Campbell and 
Silberian, 1998). Simor eta/. (1996) found no high level resistance to quinolone 
antibiotics among 1,089 Canadian isolates tested in 1994-1995 during a national survey. 
However, at the time of both studies, the use of quinolones against S. pneumoniae was 
quite limited. Our research indicates that the use of quinolones in Newfoundland has 
increased during the last several years (Figure 1 ). An increase in the use of quinolones 
may cause an increase in the level of quinolone resistance in the Newfoundland 
population in the near future. 
Resistance to erythromycin was slightly higher at 6.0% than that of tetracycline or 
levofloxacin. In a 1997 study of 845 respiratory tract isolates from across the United 
States and 202 isolates from across Canada, macrolide resistance rates in the United 
States were between 10.1% and 13.0% (Doern eta/., 1998). However, the resistance 
rates in Canada were shown to be approximately one-half those seen in the United 
States. Thus, the level of erythromycin resistance in Newfoundland is comparable to that 
of the rest of Canada. 
None of the isolates with resistance to penicillin was shown to have decreased 
sensitivity to either ceftriaxone or meropenem. A comparison of results from several 
recent cross-sectional studies and case control studies has shown that the majority of 
penicillin-intermediate strains retain full susceptibility to ceftriaxone (Wang eta/., 1998). 
The susceptibility patterns in this study are consistent with much of the research published 
thus far. However, if evidence is found which refutes previous findings, it may have 
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important implications in the future since drugs like ceftriaxone and meropenem are used 
as the next line of defence for infections which are caused by penicillin-resistant S. 
pneumoniae. 
As seen in Table 1, the majority of pneumococcal isolates came from the Health 
Care Corporation of St. John's (70.1 %). Of the isolates received from the Health Care 
Corporation of St. John's, 85.2% were susceptible to penicillin and 14.8% had 
intermediate resistance (Table 7). When comparing the susceptibilities of the other 
antibiotics, 3. 7% and 5.6% were highly resistant to tetracycline and erythromycin, 
respectively. 
The levels of antibiotic resistance indicated from the isolates received from hospital 
laboratories outside of St. John's are consistent with that seen within the Health Care 
Corporation. Of the 23 isolates tested from the laboratories outside St. John's, 43.5% had 
intermediate level resistance to penicillin and 4.3% had high resistance to erythromycin 
and tetracycline (Table 8). Although the proportion of resistant isolates is high, the small 
number of isolates submitted by some of the participating laboratories prevent us from 
making any generalizations regarding the levels of antibiotic resistance of S. pneumoniae 
within the various regions of the province. 
In this study, 26.7% of isolates were retrieved from sterile sites (Table 9). Of these 
isolates, 15.0% had intermediate level resistance to penicillin and 5.0% were resistant to 
erythromycin while 100% of isolates were susceptible to tetracycline, levofloxacin, 
ceftriaxone and meropenem (Table 9). It is important to get an accurate measure of the 
degree of resistance of pneumococci found in the blood since bacteremia is one of the 
most serious forms of disease caused by pneumococci and one of the least responsive to 
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antibiotic therapy because of the overwhelming bacterial load in the blood (Jacobs, 1992). 
During this study, a large number of isolates (n=55) were obtained from non-sterile 
sites (Table 10). Since this category of isolates also includes those from the respiratory 
tract and penicillin resistance is more common among isolates recovered from respiratory 
tract sites than from systemic sources, high levels of antibiotic resistance were expected 
(Kaplan, 1997 and Ball, 1999). The results of this study did confirm the hypothesis that 
higher levels of antibiotic resistance would be found in organisms obtained from non-
sterile sites. Approximately, 21 .8 % of isolates had intermediate resistance to penicillin, 
5.5% were resistant to tetracycline (1.8% with intermediate resistance and 3.7% with high 
resistance), 5.5% had high resistance to erythromycin and 1.8% had high resistance to 
levofloxacin (Table 10). All isolates with penicillin resistance were susceptible to both 
ceftriaxone and meropenem. 
A 20-year study which involved 11 ,407 isolates from Paris and Creteil showed that 
the degree of change in penicillin susceptibility is more prominent among noninvasive than 
invasive organisms (Geslin eta/., 1992). As previously stated, noninvasive organisms are 
those isolated from sites, such as the respiratory tract and ears, while invasive organisms 
are those isolated from typically sterile sites, such as blood and cerebrospinal fluid. The 
high level of drug resistance in organisms which reside in non-sterile sites is likely due to 
the fact that up to 80% of all antibiotics used in the community is prescribed to treat 
respiratory tract infections (Huovinen, 1998). This increase in antibiotic use will select for 
the growth of resistant organisms and the result in the transmission of resistant genes at 
these sites rather than the sterile sites where the achievable concentrations of antibiotic 
are generally lower (Wang eta/., 1998). It was shown in this study that the isolates 
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recovered from the non-sterile sites had higher levels of resistance than those from the 
sterile sites. However, the degree of penicillin resistance (i.e., intermediate) was the same 
in both sites. Therefore, the results of this study differ from the findings of Geslin et a/. 
(1992) as mentioned above. 
Approximately 36.7% of the pneumococcal isolates tested were retrieved from 
pediatric patients, those individuals under the age of 18 years (Table 11 ). It is important to 
monitor the antibiotic susceptibility rates of the pediatric group because this population 
has a decreased natural immunity compared to adults which makes them more 
susceptible to infectious organisms and subsequently results in high levels of antibiotic 
consumption. Community carriage rates are thought to be best studied in children since 
day care attendance and frequent empirical treatment with antibiotics are known risk 
factors for drug resistant pneumococcal infections (Klugman, 1990). A year long 
surveillance project conducted in South Africa investigated the role of age in carriage of 
penicillin resistant pneumococci by testing 362 nasopharyngeal isolates from children 
under the age of four and 521 nasopharyngeal isolates from children above the age of 
four (Koornhof eta/., 1992). Koornhof eta/. (1992) showed that 41% of the children under 
the age of four carried resistant pneumococci while only 6.0% of children above the age of 
four were carriers, leading the authors to the conclusion that children who are less than 
four years of age had a significantly higher carriage of resistant organisms. This study 
also supports these findings. Table 11 shows that only 82.8% of isolates obtained from 
children were sensitive to penicillin. It is also interesting to note that these isolates did not 
exhibit resistance to any of the other antibiotics tested. 
The high levels of antibiotic resistance in children has been attributed to the 
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increased frequency of single parent families as well as families where both parents work 
outside of the home (Cohen, 1999). This trend has resulted in greater use of daycare 
facilities in recent years. Within the average daycare facility, there are large numbers of 
children who generally have low natural immunity to bacterial infections. As a result, there 
is a higher incidence of infection and therefore, frequent antibiotic use within the group. 
These factors coupled with poor hygiene practices of children create the perfect setting for 
the emergence and transmission of resistant genes within the bacteria. A 1992 study in 
Kentucky tested nasopharyngeal swabs from 158 children who attended day care centers 
and compared the results to the susceptibility profile obtained from 82 children who 
attended a county health center (Dutchin eta/., 1995). Dutchin eta/. showed that children 
who attended day care had a four times greater risk of acquiring a strain of Streptococcus 
pneumoniae with high-level penicillin resistance than children who do not attend such 
facilities. In addition, it has been suggested that children less than two years of age who 
also attend daycare centers have the highest risk of being colonized and infected with 
resistant pneumococci (Jernigan eta/., 1996). For the purposes of this study, it would 
have been interesting to see how many of the children who carried S. pneumoniae were 
also attending day-care facilities and if there was a correlation between resistance and 
day care within the Newfoundland population. 
Like children, elderly patients also show a subsequent decrease in immunity which 
is related to their elevated age that put them at risk of acquiring fatal infections. For this 
reason, it is important that resistant isolates be identified in both children and senior 
citizens because the mortality rate associated with pneumococcal infections is enhanced 
at the extremes of life (Kanavaki eta/., 1994). Therefore, contracting an infection that 
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cannot be treated with antibiotics is especially threatening. Fortunately, both the 
polysaccharide or protein-conjugated pneumococcal vaccines can be used to prevent 
infections with resistant organisms in the elderly population. 
Changing human demographics, namely the increase in the number of elderly 
individuals within society, have increased the dissemination of resistant organisms, such 
as S. pneumoniae, throughout a population (Cohen, 1999). Approximately 42.1% of 
isolates tested in this study were extracted from elderly patients, those individuals over the 
age of 50 years (Table 2). Of these isolates, only 69.7% were susceptible to penicillin and 
97.0% were susceptible to tetracycline. These results are consistent with previous studies 
which have shown that elderly people are important carriers of penicillin resistant strains of 
S. pneumoniae (Jacobs, 1999). Some risk factors that have been identified as 
contributing to carriage of resistant organisms in the elderly population include 
hospitalization, prior exposure to antibiotics and tobacco use (Lund eta/., 1998). Aging 
results in a decrease in a person's natural immunity, making them more susceptible to 
infectious disease and increases the frequency with which a person uses antibiotics. 
Also, elderly people are more likely to develop chronic illnesses, such as cancer and 
coronary heart disease. A person's susceptibility to infectious diseases may then increase 
during the course of the underlying disease process while the immune system is 
challenged or as the person is taking some form of immunosuppressive therapy, such as 
chemotherapy treatment for cancer. Although the elderly patients sampled in this study 
were the predominant group for penicillin resistant pneumococci, we did not look at the 
individual risk factors that may contribute to the development or carriage of resistant 
isolates. 
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The levels of drug resistance were lower in the adult patients sampled than in the 
elderly group (Table 12). However, the adult population showed resistance to a wider 
variety of antibiotics (penicillin, tetracycline, and erythromycin) than the elderly group 
(penicillin and tetracycline) (Tables 12 and 13). 
To date, there have been no studies which compare the differences in the 
susceptibility profiles of isolates retrieved from different genders. However, penicillin 
resistance is most common in serotypes that frequently cause disease in children and 
since pneumococci are easily spread from person to person by direct contact, it is 
anticipated that males and females who have regular contact with children are at a greater 
risk of picking up resistant bacteria (Gold eta/., 1996). 
In this study, it was shown that there is very little variation in the levels of resistance 
between males and females. For example, 75.7%, 94.6% and 97.3% of the isolates 
obtained from males were susceptible to penicillin, tetracycline and erythromycin, 
respectively (Table 14). Likewise, 75.0%, 97.5% and 92.5% of the isolates obtained from 
females were susceptible to penicillin, tetracycline and erythromycin, respectively (Table 
15). Therefore, the susceptibility profiles of isolates from both genders appear similar with 
one notable exception, the resistant isolates from females were classified as intermediate 
to penicillin and high to tetracycline and erythromycin while all of the resistant isolates 
from males were classified as intermediate. This indicates that S. pneumoniae isolated 
from females are showing greater MIC values than those from males. 
There was also evidence of multiple resistance during this study. Of the isolates 
which were resistant to penicillin, three had decreased susceptibility to tetracycline and 
erythromycin, respectively. It has been shown that penicillin resistant strains are more 
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frequently resistant to other antimicrobial agents, such as macrolides, tetracycline, 
chloramphenicol and trimethoprim-sulphamethoxazole, than strains that are susceptible to 
penicillin (Pradier eta/., 1997; Jacobv, 1994; Campbell and Silberian, 1998). However, 
the mechanisms responsible for resistance to these antibiotics are unrelated to those of 
penicillin resistance. Therefore, a single organism can develop resistance to multiple 
antibiotics at the same time, but through different genetic alterations. 
Tetracycline, erythromycin, levofloxacin, ceftriaxone and meropenem appear to be 
quite active against S. pneumoniae. Table 16 showed that the MICs necessary to inhibit 
50% and 90% of the pneumococcal isolates were identified as antibiotic susceptible. The 
MIC of penicillin which inhibited 50% of the isolates was in the susceptible range as well. 
However, the MIC of penicillin which inhibited 90% of the isolates was in the intermediate 
range for that antibiotic. This indicates that a high concentration of penicillin is required to · 
eliminate most infections caused by S. pneumoniae. 
5.2 Methodology Comparison 
In this study, disk diffusion was compared to the E-test system in order to 
determine whether disk diffusion is accurate enough to be used in hospital settings alone. 
Table 3 showed that the isolates tested for penicillin resistance with the oxacillin disk 
classified 65 as being susceptible and 18 as being resistant. Using the penicillin E-test 
strips, 64 isolates were identified as being susceptible and 19 were identified as having 
intermediate resistance to the antibiotic (Table 3). 
It has been shown that some isolates identified as resistant by the oxacillin disk-
diffusion method are found to be susceptible by quantitative MIC testing while the reverse 
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is very uncommon (Lund eta/., 1998). However, during this study, it appears that both the 
oxacillin disk and penicillin E-test strips provide similar susceptibility profiles. 
The accuracy of these methods was also compared for two other antibiotics: 
erythromycin and tetracycline. Using the erythromycin disks, 79 isolates were identified as 
being susceptible and four were identified as being resistant (Figure 2). Using 
erythromycin E-test strips, 78 isolates were identified as susceptible and five were 
identified as having high resistance (Figure 2). Similarly, 81 isolates were classified as 
tetracycline susceptible and two were classified as resistant using disk diffusion while 80 
isolates were classified as being susceptible, one was classified as having intermediate 
resistance and two were classified as having high resistance when tested with tetracycline 
E-test strips (Figure 3). Both methods provide consistent susceptibility profiles for 
erythromycin and tetracycline. 
During this study, disk diffusion was shown to have high values for the specificity 
and sensitivity measurements (Tables 3, 4 and 5). Therefore, disk diffusion appears to be 
a valid method for determining antibiotic susceptibility. 
Based on the results of this study, it appears that disk diffusion could be used to 
provide a general guide for antibiotic therapy for common, uncomplicated infections. 
However, in the case of potentially fatal infections where patients need to receive the most 
effective treatment immediately, it would be important to generate the susceptibility profile 
through theE-test system because it gives a more specific profile than disk diffusion. Disk 
diffusion classifies all isolates with decreased antibiotic susceptibility as being resistant, 
but does not distinguish between intermediate and high levels of resistance. This 
information is important in determining the appropriate therapy for a serious infection and 
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can be generated through theE-test system. 
5.3 Antibiotic Consumption 
The rationale for antibiotic misuse has been based on the assumption that the risk 
of potential or possible bacterial infection is more hazardous to the patient than the risk 
from antimicrobial agents (Simmons and Stolley, 197 4). In Canada, antibiotics were the 
second most commonly prescribed drug class, accounting for 26.3 million prescriptions in 
1996 (Wang at el., 1998). Wang eta/. (1998) used the Compuscript database to generate 
information on antibiotic use in Canada and found that the number of prescriptions 
increased by 10% between 1992 and 1993, but has remained stable since then. 
Similarly, the purpose of this research project was to provide hard data showing exactly 
how much community based antibiotic consumption occurred in Newfoundland and 
Labrador from 1997 to 2000 for specific classes of drugs. 
Amoxicillin is the most frequently prescribed antibiotic in Canada at approximately 
25% of all antibiotic prescriptions (6.8 million prescriptions), followed by cephalosporins at 
3.3 million prescriptions and erythromycin at 2. 7 million prescriptions (Wang eta/., 1998). 
Of the drugs measured by the IMS database and shown in this study, penicillins, including 
amoxicillin, was the most commonly prescribed group for all infections (Figure 1 ). 
However, the use of penicillins did show a steady decline during the study period. 
Newfoundland has taken an education approach to combating the problem of 
antibiotic misuse with the Newfoundland Optimal Antibiotic Project which began in October 
1997. The purpose of the Optimal Antibiotic Project was to increase the awareness of 
physicians and the general public of the problem of antibiotic resistance and rational 
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antibiotic use. Rational antibiotic use involves taking prescribed medications correctly and 
curtailing overall use for the good of society. The Optimal Antibiotic Project was started 
with the hope that it would result in a decrease in patient demand for therapy and improve 
the ability of physicians to respond to patient expectations without antimicrobial therapy, 
thereby decreasing the population consumption of antibiotics. The information gathered 
on antibiotic use in this project indicates that the Optimal Antibiotic Project was a success. 
During the years from 1997 to 2000, the use of tetracyclines, trimethoprim and penicillins 
by the people of Newfoundland declined (Figure 1 ). Therefore, the results of this study 
indicate that educational programs, such as the Newfoundland Optimal Antibiotic Project, 
are a useful method to diminish antibiotic consumption. 
An interesting trend was seen in the use of cephalosporins and macrolides which 
initially declined, but then showed a slight increase again (Figure 1 ). The use of 
macrolides dropped again in the last year of the study while cephalosporin use remained 
high. Cephalosporins contain a number of narrow- and broad-spectrum antibiotics. 
These agents are commonly prescribed when a physician is unsure of the pathogen 
causing an ailment. The high number of prescriptions for cephalosporins seen in this 
study was unexpected due to the implementation of the Optimal Antibiotic Project 
guidelines which recommended conservative use of cephalosporins. 
The only group of antibiotics that increased in population use during the study were 
the quinolones (Figure 1). Quinolones are a relatively new class of antimicrobial agents. 
They were not commonly used in children because of their side-effects and were quite 
expensive until the mid-1990's after which time there was a decrease in cost. These 
agents were promoted by pharmaceutical companies during the 1990s as a means of 
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combating resistance to the older classes of antibiotics which had been in use for awhile. 
The increase in advertising and promotion by pharmaceutical companies may account for 
the increase in the use of these drugs during the study period. 
) 
5.4 Limitations 
One of the biggest limitations to this study was the small number of isolates that 
was tested during the study period. Although the PHL usually receives approximately 80 
pneumococcal isolates each year, we had hoped to get more isolates with active 
participation of the various hospital laboratories in order to ensure an accurate 
representation of the level of pneumococcal resistance. 
There were more isolates received from the St. John's area than the rest of the 
island. Therefore, it was impossible to compare pneumococcal resistance levels between 
provincial regions. There are several factors which may have contributed to a more 
complete sampling of isolates from the St. John's area than elsewhere in the province. 
First, the institutions which comprise the Health Care Corporation of St. John's service a 
much larger population than the other hospitals involved in this study. Therefore, a large 
number of pneumococcal isolates would be expected from this area. Second, the PHL is 
located in St. John's and as a result, participating laboratories outside of the city have to 
deal with the greater expense and effort required to transport pneumococcal isolates to 
the PHL. 
Isolates from St. Anthony and Labrador were excluded from this project because of 
difficulty maintaining viability of organisms during the time required for transportation. By 
excluding these sites, we were unable to assess the resistance rates in these areas of the 
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province, limiting the ability to generalize the results of this study to the province of 
Newfoundland and Labrador, as a whole. In addition, we were unable to assess the 
prevalence rates of antibiotic resistance in S. pneumococcus within the Aboriginal 
population of Labrador. 
At the beginning of this research project, we had hoped to receive the antibiotic 
consumption information from community pharmacies throughout Newfoundland and 
Labrador. With this information, we would have been able to access antibiotic 
consumption data within the different regions of the province and perhaps correlate this 
information with the resistance information that had been gathered. However, the 
antibiotic consumption ultimately was supplied by IMS HEALTH which provided the data 
for the whole province, not regionally. This, in addition to the small number of isolates, 
prevented any correlations from being made between resistance levels and community 
antibiotic use. 
Using the data from IMS HEALTH required us to provide antibiotic consumption 
information in terms of the number of prescriptions filled in relation to population. 
However, the internationally accepted format to describe antibiotic consumption is in terms 
of ODDs. Therefore, comparisons between consumption as indicated by this study and 
that of other published studies using the ATC/DDD System is impossible. 
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6.0 CONCLUSION 
Community carriage of antibiotic resistant strains of bacteria is now a widespread 
and increasing public health concern in many parts of the world. From this standpoint, 
strains of S. pneumoniae which are resistant to penicillin are an especially serious concern 
for several reasons, including the fact that penicillin is still considered to be the treatment 
of choice against pneumococcal infections, pneumococci are easily spread from person to 
person and are associated with significant morbidity and mortality (Gold eta/., 1996). 
Therefore, it is important to get an idea of the prevalence of antibiotic resistance in S. 
pneumoniae on a global scale. 
The purpose of this study was to provide an indicator of the level of antibiotic 
resistance among Streptococcus pneumoniae isolates in Newfoundland. It was 
successful in showing the overall trends in resistance to a specific series of antibiotics in 
this province. The rates of antibiotic resistance appear to be consistent with the trends 
observed elsewhere in Canada and the United States, if not lower in some cases. 
Some factors have been identified which put people at risk for acquiring resistant 
strains of S. pneumoniae, include the age of the person, if the person is enrolled in or 
works in a day care facility, if the person has an illness which may suppress the immune 
system or if the person has been hospitalized in recent years (Kaplan, 1997). It has also 
been shown that the use of antibiotic drugs for prophylactic or therapeutic purposes in 
humans or for veterinary or agricultural purposes are responsible for providing the 
selective pressure favors the overgrowth of resistant organisms (Gold eta/., 1996). 
However, there is much more research required. For example, the specific mechanisms 
of resistance need to be identified, new antibiotics need to be developed, more effective 
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uses of the present drugs need to be discovered, the best forms of therapy need to be 
ascertained for infections due to multiresistant organisms and, most importantly, we need 
to figure out how to prevent these types of infections. Unfortunately, this research project 
was unable to provide any information on possible risk factors since it was not able to 
provide an accurate depiction of resistance levels on the basis of geographic region, 
patient age, patient sex or specimen source because of the small number of specimens 
collected during the study period. 
The incidence of drug resistant S. pneumoniae has been shown to vary not only 
between communities, but also within a single community and even between different 
types of patients (Campbell and Silberian, 1998). For this reason, many researchers have 
emphasized the importance of developing a surveillance system and testing 
methodologies to monitor the factors which are contributing to microbial resistance as well 
as changing resistance patterns. This study showed that disk diffusion alone is a 
reasonable method for assessing microbial susceptibility in uncomplicated infections. 
There have been some improvements in resistance education and awareness 
during the last few years. This is partially due to successful projects, such as the one in 
Newfoundland, which illustrate the effectiveness of educational tools as a method of 
reducing the problem of resistant microbes. For example, this study showed that the use 
of penicillins and macrolides decreased after the implementation of the Optimal Antibiotic 
Project. As a result, many wealthy countries are beginning to promote the judicious use of 
antimicrobial agents by their physicians and the public. Since the severity of the problem 
has been recognized and steps are being taken to correct it, we are hoping that eventually 
the problem of antibiotic resistance will be decreased. 
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8.0 APPENDIX A 
Protocol for Recieving Pneumococcal Isolates 
The Newfoundland Public Health Laboratory (PHL) carries out a province-wide 
surveillance program for antimicrobial resistance for strains of Streptococcus 
pneumoniae (SPN). 
• 
• 
• 
• 
Hospital-based Microbiology Labs across the province forward isolates of SPN, 
especially those isolated from normally sterile sites such as blood and CSF, to PHL 
via courier on blood agar plates. 
The PHL subcultures the isolates to blood agar (BA) to check for viability and purity . 
Heavy suspensions of SPN are prepared in defribrinated sheep's blood and the 
suspensions are frozen at -70° C to maintain viability until susceptibility test panels 
are performed. 
Antimicrobial MIC susceptibility tests are performed using E-test (A. B. Biodisks) . 
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9.0 APPENDIX 8 
Protocol For Susceptibility Testing of S. Pneumoniae 
Day 1 
1.) Remove cultures to be tested from the ultrafreeze at the Newfoundland PHL. 
2.) Allow the vials to defrost. 
3.) Divide blood agar (BA) plates into four quadrants with marking pen and subculture 
each isolate onto a quadrant of the BA plate using a 10 mel loop. 
4.) Incubate the BA plate in C02 at 35-36 °C for 18 to 24 hours. 
Day2 
1.) Prepare suspensions of the test organism by dipping loop containing isolate into 0.9% 
normal saline or Mueller Hinton Broth. Suspension should be equivalent to 0.5 McFarland 
control (1.0 McFarland for mucoid strains). Suspension should be used within 15 minutes 
of preparation. 
2.) Dip sterile cotton swab into suspension and rotate swab several times against the 
inside wall of the tube to remove excess inoculum. 
3.) Inoculate the surface of the BA plate by streaking the plate in three planes. Plate 
should be uncapped for 3-5 minutes to allow excess moisture to evaporate. 
4.) Add a single E-test strip to one BA plate for each isolate or four disks may be added to 
one BA plate for each isolate. One BA plate per isolate should be incubated with an 
optochin disk to verify that the isolate isS. pneumoniae. 
5.) BA plates should be inverted and incubated for 20 to 24 hours at 35 oc in 5-7% C02• 
Day3 
1.) The zone of inhibition should be measured for each strip/disk and interpreted 
according to NCCLS guidelines. 
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10.0 APPENDIX C 
Optimal Antibiotic Project 
The Newfoundland Optimal Antibiotic Project began in 1997 in an attempt to 
increase awareness of antibiotic resistance amongst physicians and the population at 
large as well as teach people about rational antibiotic use through a media campaign. It is 
a collaborative effort between physicians, pharmacists, pharmaceutical companies and 
government which was designed to measure resistance in clinical isolates of bacteria, 
antibiotic use and health care resource use related to community acquired infections. 
In 2000, a proposal was generated to tum the Optimal Antibiotic Project into an ongoing 
program. The program would consist of the following three components: 
1.) Measurement of Resistance in Clinical Bacteria 
It was proposed that all hospitals with microbiology laboratories within the province 
of Newfoundland and Labrador measure antibiotic resistance in clinical bacterial isolates. 
This information would then be collated and analyzed centrally. 
2.) Measurement of Resistance in "Normal" Bacteria 
Since it is felt that monitoring resistance prevalence in bacteria from people outside 
the hospital setting is a more sensitive measure of the degree of the problem within a 
population, it was proposed that routine sampling of normal bacteria isolated from the 
general population occur in a systematic fashion. The routine sampling of these isolates 
would then be used for monitoring the development of resistance. 
3.) Measurement of Antibiotic Use 
It is important to have good measurements of antibiotic use in order to assess the 
efficiency of policy and how prescribing practices effect resistance prevalence in a 
population. It was proposed that all antibiotic information be electronically collected from 
community and hospital pharmacies throughout Newfoundland and Labrador. This 
information could then be processed centrally. 
The ultimate goal of this program was to provide information which would allow the 
development of treatment guidelines, specific to the province of Newfoundland and 
Labrador, taking into account local susceptibility patterns. Regular reports would be 
compiled for physicians and policy makers which would allow informed decisions to be 
made regarding formulary recommendations. The general public would also receive 
regular reports providing information on local antibiotic consumption and resistance 
prevalence. 
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